Probi is a global, science-driven company that develops and manufactures clinically documented biotic solutions for gut, immune, and metabolic health. It supports partners worldwide with research-backed ingredients and finished products.
Probi is a global, science-driven company that specializes in the research, development, and production of clinically documented biotic solutions. Founded in 1991 at Lund University in Sweden, the company operates across the entire biotics field, leveraging expertise in R&D, fermentation, and manufacturing to deliver high-quality ingredients and finished products. Probi distinguishes itself through a strong focus on scientific rigor, utilizing over 350 global patents and numerous peer-reviewed studies to validate the efficacy of its bacterial strains. As a vertically integrated player, it manages the complete value chain—from initial research and clinical trials to production and commercialization—ensuring that its products meet strict regulatory and GMP standards before reaching global markets.
By providing science-backed biotic solutions, Probi helps customers and partners address diverse health areas, including gut, immune, metabolic, and oral health. The company serves a global base, offering customized formulations and ingredient formats that help brands fulfill consumer demands for effective health products. Through strategic partnerships, global supply chain capabilities, and state-of-the-art manufacturing facilities, Probi empowers people to improve their health by managing their microbiome. Now a subsidiary of Symrise AG, the company continues to advance its mission of improving lives through the science of biotics, supported by a commitment to sustainability and ongoing innovation.